Insulin resistance as a risk marker for GDM in PCOS :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Early insulin resistance doubles gestational diabetes risk in PCOS

Polycystic ovary syndrome Polycystic ovary syndrome
Polycystic ovary syndrome Polycystic ovary syndrome

What's new?

Early-pregnancy insulin resistance is independently associated with approximately twofold higher odds of gestational diabetes mellitus in women with PCOS.

Pregnancy already presents unique metabolic challenges for women with polycystic ovary syndrome (PCOS), but could insulin resistance (IR) make them more vulnerable to gestational diabetes? New research suggests that women with PCOS who have IR early in pregnancy may face substantially higher odds of developing gestational diabetes mellitus (GDM), even after accounting for body mass index (BMI) and other potential confounders.

This retrospective cohort study, led by Zhifen Hua et al., encompassed 168 pregnant women with PCOS. Based on the homeostasis model assessment of insulin resistance (HOMA-IR), subjects were classified into two groups: 52 women with IR (HOMA-IR ≥2.77) and 116 without IR. The authors used multivariable binary logistic regression to examine the link between IR and GDM, adjusting for age, BMI, family history of diabetes, and conception mode.

Key findings

  • Higher GDM incidence: GDM developed in 30.77% of women with IR compared with 17.24% of those without IR.
  • Independent association: IR remained independently associated with GDM after adjustment (adjusted odds ratio [aOR]: 2.09).
  • Role of BMI: Higher BMI was also independently linked with increased GDM odds (odds ratio: 1.19 per kg/m²). Women with IR had markedly higher BMI.
  • Other maternal outcomes: No pivotal between-group differences were noted in gestational hypertension, polyhydramnios (excessive buildup of amniotic fluid), or premature rupture of membranes.
  • Neonatal and metabolic outcomes: Thyroid function, lipid profiles across trimesters, neonatal birth weight, and other perinatal outcomes were similar between groups.

Hence, assessing IR early in pregnancy may help identify PCOS sufferers who are more likely to develop GDM. Early metabolic screening and appropriate risk-based management could support closer monitoring during pregnancy. Nevertheless, the retrospective observational design does not establish causality. Prospective studies are needed to validate the connection and determine whether targeted metabolic management can minimize GDM incidence in PCOS sufferers.

Source:

Journal of International Medical Research

Article:

Effects of insulin resistance on pregnancy outcomes and complications in women with polycystic ovary syndrome

Authors:

Zhifen Hua et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: